JEREMY WILEY: Open Payments
NPI 1508306689 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 11 payments from 7 companies in 2025. Trend: 2023 $88 · 2024 $101 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $142 |
| Astellas Pharma US Inc | 2 | $34 |
| Amgen Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| CeQur Corporation | 1 | $18 |
| Corcept Therapeutics | 1 | $17 |
Products named: MOUNJARO, Veozah, QULIPTA, XIFAXAN, REPATHA, CeQur Simplicity, JARDIANCE, Korlym.
Industry payments across LA — which companies pay providers there.
